Health Catalyst Inc’s recent filing unveils that its Director Gallagher Duncan unloaded Company’s shares for reported $31415.0 on Dec 23 ’24. In the deal valued at $6.98 per share,4,500 shares were sold. As a result of this transaction, Gallagher Duncan now holds 74,438 shares worth roughly $0.53 million.
Then, DUNCAN GALLAGHER bought 4,500 shares, generating $31,905 in total proceeds.
Before that, Llewelyn Linda sold 6,442 shares. Health Catalyst Inc shares valued at $50,794 were divested by the Chief People Officer at a price of $7.88 per share. As a result of the transaction, Llewelyn Linda now holds 98,702 shares, worth roughly $0.7 million.
KeyBanc Capital Markets downgraded its Health Catalyst Inc [HCAT] rating to a Sector weight from a an Overweight in a research note published recently. A number of analysts have revised their coverage, including Evercore ISI’s analysts, who increased its forecast for the stock in early January from “an In-line” to “an Outperform”. Barclays began covering HCAT with “an Overweight” recommendation on January 03, 2024. JP Morgan revised its rating on December 13, 2023. It rated HCAT as “an Overweight” which previously was an “a Neutral”.
Price Performance Review of HCAT
On Friday, Health Catalyst Inc [NASDAQ:HCAT] saw its stock fall -0.14% to $7.08. Over the last five days, the stock has gained 1.58%. Health Catalyst Inc shares have fallen nearly -23.54% since the year began. Nevertheless, the stocks have fallen -26.02% over the past one year. While a 52-week high of $11.41 was reached on 01/12/24, a 52-week low of $5.42 was recorded on 08/07/24. SMA at 50 days reached $7.99, while 200 days put it at $7.24.
Levels Of Support And Resistance For HCAT Stock
The 24-hour chart illustrates a support level at 6.84, which if violated will result in even more drops to 6.59. On the upside, there is a resistance level at 7.26. A further resistance level may holdings at 7.44. The Relative Strength Index (RSI) on the 14-day chart is 37.39, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.54, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 83.42%. Stochastics %K at 13.62% indicates the stock is a buying.
How much short interest is there in Health Catalyst Inc?
A steep rise in short interest was recorded in Health Catalyst Inc stocks on 2024-12-13, growing by 25541.0 shares to a total of 2.56 million shares. Yahoo Finance data shows the prior-month short interest on 2024-11-15 was 2.53 million shares. There was a rise of 1.0%, which implies that there is a positive sentiment for the stock.